A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
Wafaa B. Alsoussi(Washington University in St. Louis), Ali H. Ellebedy(Washington University in St. Louis), Julie M. Fox(National Institutes of Health), Larissa B. Thackray(Washington University in St. Louis), Tingting Lei(Washington University in St. Louis), James Brett Case(Washington University in St. Louis), Julian Q. Zhou(AbCellera (Canada)), Ahmed O. Hassan(Washington University in St. Louis), Haiyan Zhao(Hubei University of Medicine), Aaron J. Schmitz(Washington University in St. Louis), Rita E. Chen(Washington University in St. Louis), Fatima Amanat(Icahn School of Medicine at Mount Sinai), Corey T. Watson(University of Louisville), Daved H. Fremont(Washington University in St. Louis), Jackson S. Turner(Washington University in St. Louis), Steven H. Kleinstein(Yale University), Michael Diamond(Washington University in St. Louis), Florian Krammer(Semmelweis University), Amena A. Rizk(Washington University in St. Louis), Natasha M. Kafai(Washington University in St. Louis), Emma S. Winkler(Washington University in St. Louis), Katherine M. McIntire(Washington University in St. Louis)
Cited by 223
Related Papers
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
The continued threat of emerging flaviviruses
|Nature Microbiology|2020|1.1k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
|Nature Immunology|2020|997